Louis Luttrell to Receptor, Parathyroid Hormone, Type 1
This is a "connection" page, showing publications Louis Luttrell has written about Receptor, Parathyroid Hormone, Type 1.
Connection Strength
2.500
-
Translating in vitro ligand bias into in vivo efficacy. Cell Signal. 2018 01; 41:46-55.
Score: 0.551
-
Emergent biological properties of arrestin pathway-selective biased agonism. J Recept Signal Transduct Res. 2013 Jun; 33(3):153-61.
Score: 0.412
-
Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity. Methods Enzymol. 2013; 522:229-62.
Score: 0.407
-
'Biasing' the parathyroid hormone receptor: a novel anabolic approach to increasing bone mass? Br J Pharmacol. 2011 Sep; 164(1):59-67.
Score: 0.371
-
A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation. Sci Transl Med. 2009 Oct 07; 1(1):1ra1.
Score: 0.326
-
Informatic deconvolution of biased GPCR signaling mechanisms from in vivo pharmacological experimentation. Methods. 2016 Jan 01; 92:51-63.
Score: 0.120
-
Delineation of a conserved arrestin-biased signaling repertoire in vivo. Mol Pharmacol. 2015 Apr; 87(4):706-17.
Score: 0.118
-
A high-content, live-cell, and real-time approach to the quantitation of ligand-induced ?-Arrestin2 and Class A/Class B GPCR mobilization. Microsc Microanal. 2013 Feb; 19(1):150-70.
Score: 0.102
-
Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation. J Biol Chem. 2006 Apr 21; 281(16):10856-64.
Score: 0.063
-
Exploring G protein-coupled receptor signaling networks using SILAC-based phosphoproteomics. Methods. 2016 Jan 01; 92:36-50.
Score: 0.030